Presentation TCT 2019 Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy Presenter: Liwen Liu September 25, 2019
News Conference News HFSA 2019 DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF L.A. McKeown September 16, 2019
News Industry News Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves September 05, 2019
News Conference News ESC 2019 PARAGON-HF Misses Primary Endpoint, but Hints of Benefit Seen Todd Neale September 01, 2019
News Daily News STICH Myocardial Viability at 10 Years: Still No Link With CABG Effects Todd Neale August 21, 2019
News Daily News Renal Denervation for Chagas Disease-Related HF Proves Safe in Pilot Study Todd Neale August 01, 2019
News Daily News Preemptive Alcohol Septal Ablation May Help Prevent LVOT Obstruction in TMVR Yael L. Maxwell July 11, 2019
News Daily News Carpal Tunnel Linked to Higher Rates of Amyloidosis and Heart Failure L.A. McKeown July 02, 2019
News Opinion Fellow Talk Hemodynamics: The Forgotten Branch of Cardiology Mesfer Alfadhel, MD June 28, 2019
News Industry News Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation June 24, 2019
News Conference News TVT 2019 Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI Michael O'Riordan June 17, 2019
News Conference News TVT 2019 Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry Shelley Wood June 17, 2019
Presentation TVT 2019 Gender Differences in the Safety of Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy Presenter: Abhishek Sharma June 14, 2019
News Conference News ESC Heart Failure 2019 Weaning Off Diuretics in Stable Heart Failure? ReBIC-1 Hints at Possibilities Shelley Wood May 28, 2019
News Conference News HRS 2019 Cancer Survivors With Heart Failure Respond Well to CRT Todd Neale May 14, 2019
News Industry News FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy May 13, 2019
News Daily News In the Wake of Guidelines, Antibiotic Prophylaxis for Infective Endocarditis Declined for Moderate-Risk Patients L.A. McKeown May 07, 2019
News Daily News Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy Michael O'Riordan May 06, 2019
News Industry News FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis May 06, 2019
News Industry News FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial May 02, 2019